BMED Holdings Information

BMED is an equity ETF with a total of 62 individual holdings. The top holdings are Merck & Co. stock at 5.82%, Gilead Sciences at 5.11%, Edwards Lifesciences at 4.53%, Johnson & Johnson at 4.40%, and Thermo Fisher Scientific at 3.97%.

Total Holdings

Top 10 Percentage

42.03%

Asset Class

Equity

ETF Category

Health

Assets

10.94M

PE Ratio

27.75

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	MRK	Merck & Co., Inc.	5.82%	5,064
2	GILD	Gilead Sciences, Inc.	5.11%	4,165
3	EW	Edwards Lifesciences Corporation	4.53%	5,726
4	JNJ	Johnson & Johnson	4.40%	1,955
5	TMO	Thermo Fisher Scientific Inc.	3.97%	812
6	DHR	Danaher Corporation	3.84%	2,077
7	CRL	Charles River Laboratories International, Inc.	3.68%	1,783
8	BIIB	Biogen Inc.	3.64%	1,935
9	WAT	Waters Corporation	3.53%	1,035
10	ABBV	AbbVie Inc.	3.50%	1,528
11	AMGN	Amgen Inc.	3.50%	1,046
12	MRNA	Moderna, Inc.	3.38%	5,948
13	MTD	Mettler-Toledo International Inc.	3.30%	274
14	ILMN	Illumina, Inc.	3.22%	1,876
15	VRTX	Vertex Pharmaceuticals Incorporated	3.02%	690
16	TECH	Bio-Techne Corporation	2.46%	3,805
17	DXCM	DexCom, Inc.	2.45%	3,493
18	NBIX	Neurocrine Biosciences, Inc.	2.20%	1,423
19	SWX: NOVN	Novartis AG	2.17%	1,579
20	SWX: ROP	Roche Holding AG	2.00%	540
21	ARGX	argenx SE	1.93%	250
22	XTSLA	BLK CSH FND TREASURY SL AGENCY	1.89%	210,000
23	CYTK	Cytokinetics, Incorporated	1.88%	2,600
24	IQV	IQVIA Holdings Inc.	1.76%	929
25	INCY	Incyte Corporation	1.73%	1,645

Showing 25 of 62 holdings

Subscribe to see the full list

Activate Now

As of Jul 16, 2026